Cognigenics, Inc. — Form D

Cognigenics, Inc. of EAGLE, ID, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-17. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-08-17
• Form: D
• Accession: 0001940809-22-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.6M
• Amount sold: $1.6M
• Minimum investment: $442K
• Investors: 3
• Date of first sale: 2022-06-13
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-456119

Issuer

• Name: Cognigenics, Inc.
• CIK: 0001940809
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 1372 SOUTH EAGLE ROAD, EAGLE, ID, 83616
• Phone: (772) 324-8800

Officers, directors & promoters (9)

More

• CIK 1940809 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search